Patients with chronic pancreatitis face a significantly increased risk of developing pancreatic cancer compared to individuals without pancreatitis. According to the systematic review and meta-analysis, chronic pancreatitis is associated with a hazard ratio (HR) of 7.
Patients with chronic pancreatitis face a significantly increased risk of developing pancreatic cancer compared to individuals without pancreatitis. According to the systematic review and meta-analysis, chronic pancreatitis is associated with a hazard ratio (HR) of 7.82 (95% CI: 5.25–11.65), indicating that the risk is nearly eight times greater for these patients. Chronic pancreatitis poses a higher risk than acute pancreatitis, which has an HR of 3.54 (95% CI: 1.84–6.80). The stronger association with chronic pancreatitis highlights the role of long-term inflammation in the development of pancreatic cancer.
The study also found that the risk is particularly elevated for pancreatic ductal adenocarcinoma (PDAC) (HR: 6.57, 95% CI: 5.31–8.14) and intraductal papillary mucinous neoplasms (IPMN) (HR: 17.19, 95% CI: 8.83–33.46). These findings suggest that chronic pancreatitis may play a critical role in the development of both malignant and precancerous pancreatic lesions.
Given the significant risk, patients with chronic pancreatitis should be considered a high-risk group for pancreatic cancer. This underscores the need for further research into cost-effective screening and monitoring strategies to detect pancreatic cancer or precancerous lesions early in this vulnerable population.
Introduction: Advanced biliary tract cancer (BTC) carries a poor prognosis, with limited improvements in survival despite the addition of immune checkpoint inhibitors to standard gemcitabine–cisplatin chemotherapy. This phase II trial evaluated ivonescimab, a novel PD-1/VEGF...
Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have become a cornerstone in the management of type 2 diabetes because of their excellent glycemic, cardiovascular, and weight-loss benefits. However, concerns remain regarding their potential association with...
Introduction: Patients undergoing pancreatoduodenectomy for non invasive intraductal papillary mucinous neoplasm (IPMN) require long-term surveillance because of the risk of disease recurrence in the pancreatic remnant. New pancreatic duct (PD) dilatation is commonly detected during...
• This study evaluated 1,063 patients undergoing pancreatic surgery; 11% developed conventionally defined chyle leak. • Most clinically relevant cases were grade B, while no grade C leaks were reported. • A minimally invasive surgical...
Introduction: Endoscopic ultrasound (EUS)-guided drainage has become the preferred minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...
Introduction: Fatty pancreas disease (FPD), also known as intrapancreatic fat deposition, has emerged as an important metabolic condition closely linked to obesity, insulin resistance, and type 2 diabetes mellitus (T2DM). Although ectopic fat accumulation in...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.